|

Rhomboid Intercostal Block vs Erector Spinae Block

RECRUITINGN/ASponsored by Cairo University
Actively Recruiting
PhaseN/A
SponsorCairo University
Started2025-07-01
Est. completion2026-07-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted

Summary

This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* patients undergoing thoracotomy for lung cancer

Age ≥ 18 years and ≤ 65 years

ASA physical status II or III

Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m²

Willing and able to provide informed consent

Exclusion Criteria:

Patient refusal

ASA physical status IV

Age \< 18 years or \> 65 years

BMI \< 20 kg/m² or \> 35 kg/m²

Known allergy or contraindication to local anesthetics or opioids used in the study

History of chronic pain or psychological disorders

Contraindications to regional anesthesia (e.g., local infection, coagulopathy, pre-existing peripheral neuropathy)

Severe respiratory, cardiac, hepatic, or renal disease

\-

Conditions2

CancerLung Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.